NASDAQ: AUPHAurinia Pharmaceuticals Inc Stock Ownership - Who owns Aurinia Pharmaceuticals?
Insider buying vs selling
Have Aurinia Pharmaceuticals Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Greg Keenan | Chief Medical Officer | 2025-03-07 | 8,305 | $8.23 | $68.35kSell |
| Kevin Tang | Director | 2025-03-04 | 100,000 | $8.09 | $809.00kBuy |
| Joseph M. Miller | Chief Financial Officer | 2025-03-04 | 56,154 | $7.92 | $444.74kSell |
| Matthew Maxwell Donley | Chief Operating Officer | 2025-03-04 | 58,991 | $7.92 | $467.21kSell |
| Kevin Tang | Director | 2025-03-04 | 500,000 | $7.92 | $3.96MBuy |
| Peter Greenleaf | Chief Executive Officer | 2025-03-04 | 164,947 | $7.92 | $1.31MSell |
| Stephen P. Robertson | EVP General Counsel | 2025-03-04 | 57,607 | $7.92 | $456.25kSell |
| Kevin Tang | Director | 2025-03-04 | 148,038 | $8.00 | $1.18MBuy |
| Joseph M. Miller | Chief Financial Officer | 2025-03-03 | 61,859 | $8.00 | $494.87kSell |
| Matthew Maxwell Donley | Chief Operating Officer | 2025-03-03 | 65,902 | $8.00 | $527.22kSell |
AUPH insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when AUPH insiders and whales buy or sell their stock.
AUPH Shareholders
What type of owners hold Aurinia Pharmaceuticals Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Kevin Tang | 7.30% | 10,029,500 | $81.44M | Insider |
| Blackrock Inc | 6.52% | 8,951,685 | $72.69M | Institution |
| Tang Capital Management LLC | 6.14% | 8,429,500 | $68.45M | Institution |
| Armistice Capital LLC | 4.66% | 6,400,000 | $51.97M | Institution |
| Nea Management Company LLC | 2.89% | 3,969,834 | $32.24M | Institution |
| State Street Corp | 2.12% | 2,918,039 | $23.69M | Institution |
| Peter Greenleaf | 1.30% | 1,788,945 | $14.53M | Insider |
| Geode Capital Management LLC | 1.28% | 1,764,395 | $14.33M | Institution |
| Goldman Sachs Group Inc | 1.28% | 1,752,174 | $14.23M | Institution |
| Vanguard Group Inc | 1.26% | 1,729,948 | $14.05M | Institution |
AUPH vs Biotech Stocks
Aurinia Pharmaceuticals Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.